TATAA Biocenter, Yikon Partner Tuesday, February 09, 2016 TATAA Biocenter and Yikon Genomics has Announced Strategic Partnership to distribute Yikon’s MALBACTM products for single cell profiling and YK-PGSTM Solutions in Europe.DNAnexus, Sapio Collaborate Thursday, February 04, 2016 DNAnexus Inc., the global leader in cloud-based genome informatics and data management, has announced the integration of its cloud-based genomics platform with Sapio Sciences’ Exemplar Next Generation Sequencing (NGS) Laboratory Information Management System (LIMS) solution for clinical and research labs. Illumina Signs Multiple Biobank Deals Wednesday, February 03, 2016 MEGA array family and next-generation sequencing to support comprehensive genomics approach toward personalized medicine.
Swift Biosciences, SeraCare Partner Monday, February 01, 2016 Swift Biosciences and SeraCare Life Sciences have announced a partnership to accelerate development of a novel circulating tumor DNA reference material. Venaxis Announces Transaction with Strand Life Sciences Thursday, January 28, 2016 Venaxis®, Inc. has announced that it has entered into a series of agreements for a transaction with Strand Life Sciences Private Limited (Strand LS) and its shareholders. Illumina Appoints Dr. Frances Arnold to Its Board of Directors Thursday, January 28, 2016 Illumina, Inc. has announced that Dr. Frances Arnold has joined the company’s Board of Directors. Dr. Arnold manages a research group at the California Institute of Technology and is the Director of the Donna and Benjamin M. Rosen Bioengineering Center.Illumina Acquires Conexio Genomics Wednesday, January 27, 2016 Acquisition strengthens company’s ability to deliver sample-to-report solutions for HLA typing.Agilent Extends Agreement with PerkinElmer on Bioanalyzer Chips Thursday, January 21, 2016 PerkinElmer supplies chips for Agilent's popular 2100 Bioanalyzer system.Amarantus to Merge Diagnostics Unit with Avant Wednesday, January 20, 2016 Amarantus Bioscience Holdings and Avant Diagnostics have announced they have entered into a Letter of Intent (the "LOI") to merge an Amarantus wholly-owned subsidiary, Amarantus Diagnostics, into Avant Diagnostics.